Healthcare Entrepreneur Greg Serrao Joins Summit Partners as Executive-in-Residence

BOSTON, MA--(Marketwired - Apr 27, 2016) - Summit Partners, a global growth equity investor, today announced the addition of Greg Serrao to the firm's Executive-in-Residence ("EIR") program. In this role, Mr. Serrao will work closely with Summit's Healthcare & Life Sciences team to identify new investment opportunities within growth-stage healthcare companies.

Mr. Serrao joins Summit's EIR program from American Dental Partners ("ADPI"), a company he founded in 1996 with financial and strategic support from Summit. Mr. Serrao served as Chief Executive Officer from 1996 until 2015, rapidly scaling the business and leading the company's IPO in 1998. Summit remained involved with the company's Board of Directors through 2008. Today, American Dental Partners is one of the largest providers of business services to multi-disciplinary dental groups in the United States and is affiliated with more than 25 dental group practices located in 21 states.

Since late 2015, Mr. Serrao has served as ADPI's Executive Chairman. Prior to American Dental Partners, Serrao served as President of National Specialty Services, a subsidiary of Cardinal Health, and Vice President of Corporate Development at Cardinal Health. He began his career as an investment banker for Dean Witter Reynolds, where he co-founded its healthcare investment banking group and specialized in mergers, acquisitions and public equity offerings.

"Greg's success as an entrepreneur and as a CEO has been impressive," said Darren Black, a Boston-based Managing Director at Summit Partners. "He is an excellent operator with a keen talent for driving growth -- organically and through acquisitions. We are thrilled to continue our partnership with Greg, and we feel confident about the impact he will have."

"Summit proved to be a great partner throughout their investment in ADPI. Given our history together, it was an easy decision to join the Summit EIR program when the opportunity arose," said Serrao. "I'm excited to again work alongside the Summit healthcare team and to bring my experience to new opportunities."

Summit has been active in the healthcare & life sciences sector for more than three decades. Since the firm's founding in 1984, Summit has partnered with more than 90 companies in growth-oriented sectors across the healthcare value chain, including physician-based practice management, home health, healthcare IT, accountable care organizations, laboratory services, and lab-based diagnostics.

Summit's EIR program is an established and successful element of the firm's growth-oriented investing strategy. Since its inception in 1999, the program has connected senior industry executives who work alongside Summit's sector teams to identify investment opportunities, conduct due diligence, and create and support value creation plans for the companies with which Summit has partnered.

About Summit Partners
Founded in 1984, Summit Partners is a global growth equity firm that is currently investing more than $7.2 billion into equity and fixed income opportunities. Summit has invested in more than 430 companies in healthcare, life sciences, technology and other growth sectors. These companies have completed more than 135 public offerings, and more than 160 have been acquired through strategic mergers and sales. Notable healthcare companies backed by Summit Partners include Anesthetix, CareCentrix, HealthCare Partners, Lincare, MEDNAX, MDVIP, Modernizing Medicine, National Veterinary Associates and Wellcentive. Summit maintains offices in North America and Europe, and invests in companies around the world. In addition to the EIR program, Summit's team offers strategic and tactical support at an operational level through its Peak Performance Group, expertise in structuring and financing transactions through its Capital Markets Team, and dedicated recruiting resources through its Talent and Recruiting Team. For more information, visit www.summitpartners.com or follow on Twitter at @SummitPartners.

In the United States of America, Summit Partners operates as an SEC-registered investment advisor. In the United Kingdom, this document is issued by Summit Partners LLP, a firm authorized and regulated by the Financial Conduct Authority. Summit Partners LLP is a limited liability partnership registered in England and Wales with registered number OC388179 and its registered office is at 20-22 Bedford Row, London, WC1R 4JS, UK. This document is intended solely to provide information regarding Summit Partners' potential financing capabilities for prospective portfolio companies.